Chest, Vol 98, 1322-1326, Copyright © 1990 by American College of Chest Physicians

ARTICLES

Utility of fiberoptic bronchoscopy in nonresolving pneumonia

SH Feinsilver, AM Fein, MS Niederman, DE Schultz and DH Faegenburg
Department of Pulmonary and Critical Care Medicine, Winthrop University Hospital, Mineola, NY.

Although fiberoptic bronchoscopy (FOB) has been traditionally used to evaluate nonresolving pneumonia, its efficacy is unknown. We, therefore, reviewed FOB in 35 consecutive patients who had (1) a roentgenographic infiltrate, (2) cough, (3) either temperature greater than 38.1 degrees C, leukocytosis, sputum production, (4) symptoms present for at least ten days, and antibiotic therapy for at least one week. Known lung cancer and AIDS were excluded. Fiberoptic bronchoscopy was diagnostic in 86 percent (12/14) in whom a specific cause was found. No patient had endobronchial cancer. Two patients with nondiagnostic FOB and persistent systemic symptoms had open lung biopsy specimens showing Wegener's granulomatosis and bronchiolitis obliterans with organizing pneumonia (BOOP). Twenty-one patients with nondiagnostic FOB had no final diagnoses other than community-acquired pneumonia. We conclude that FOB is extremely useful in finding a specific diagnosis for a nonresolving pneumonia when a specific diagnosis can be made. Fiberoptic bronchoscopy was most likely to yield a specific diagnosis in nonsmoking patients with multilobar infiltrates of long duration and could have been avoided in older, smoking, or otherwise compromised patients with lobar or segmental infiltrates with no decrease in diagnostic yield in our series.

This article has been cited by other articles:

				R. Menendez and A. Torres Treatment Failure in Community-Acquired Pneumonia Chest, October 1, 2007; 132(4): 1348 - 1355. [Abstract] [Full Text] [PDF]

				K. Stralin, J. Korsgaard, and P. Olcen Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage Eur. Respir. J., September 1, 2006; 28(3): 568 - 575. [Abstract] [Full Text] [PDF]

				M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180. [Abstract] [Full Text] [PDF]

				W-S Lim Identifying failure of empirical treatment for pneumonia: vigilance and common sense Thorax, November 1, 2004; 59(11): 918 - 919. [Full Text] [PDF]

				S V Baudouin The pulmonary physician in critical care 3: Critical care management of community acquired pneumonia Thorax, March 1, 2002; 57(3): 267 - 271. [Abstract] [Full Text] [PDF]

				M. S. Niederman, L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, et al. Guidelines for the Management of Adults with Community-acquired Pneumonia . Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1730 - 1754. [Full Text] [PDF]

				F. ARANCIBIA, S. EWIG, J. A. MARTINEZ, M. RUIZ, T. BAUER, M. A. MARCOS, J. MENSA, and A. TORRES Antimicrobial Treatment Failures in Patients with Community-acquired Pneumonia . Causes and Prognostic Implications Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 154 - 160. [Abstract] [Full Text]

				J. G. Bartlett and L. M. Mundy Community-Acquired Pneumonia N. Engl. J. Med., December 14, 1995; 333(24): 1618 - 1624. [Full Text] [PDF]